Stockreport

Verrica Pharmaceuticals Enrolls First Patient in Phase 2 Trial of VP-102 for the Treatment of External Genital Warts

Verrica Pharmaceuticals Inc.  (VRCA) 
Last verrica pharmaceuticals inc. earnings: 3/13 07:00 am Check Earnings Report
PDF WEST CHESTER, Pa., June 27, 2019 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (Verrica) (Nasdaq: VRCA), a medical dermatology company committed to the development [Read more]